You are here: Home PPA (Phenylpropanolamine)

PPA (Phenylpropanolamine)

E-mail Print PDF

Phenylpropanolamine, which is also known as PPA, is a chemical that was used in hundreds of over the counter and prescription medications. PPA was often the active ingredient in diet drugs, nasal decongestants and cough medications. In 1990 U.S. consumers bought about 6 billion doses of medication that containted PPA. In November 2000, US regulators first moved to take Phenylpropanolamine off the market because of dangerous side effects that caused hemorrhagic strokes.

Phenylpropanolamine (PPA) was used in many popular over the counter medications. Dexatrim, Acutrim, Robitussin, Comtrex, Triaminic, and Tavist D are just a few brands that had products containing PPA. The Food and Drug Administration (FDA) said it has asked all drug companies to voluntarily stop marketing products containing PPA and is seeking to make the sale of PPA products, both prescription and over-the-counter, illegal.

While research pointed to a higher risk of hemorrhagic strokes, or bleeding into the brain, for women, the FDA cautioned that men were also at risk. The strokes occurred within three days after people took the products

 

Fill Out a Form

Defective Drugs Form


 

Basic Information

 
 
 
 
 
 

Details About Injury

 
Drug Complained of:
 
 
 
  
 
 

FDA Recalls

Food and Drug Administration--Recalls/Safety Alerts